Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Blepharonasofacial syndrome is a rare otorhinolaryngological malformation syndrome characterized by a distinctive mask-like facial dysmorphism, lacrimal duct obstruction, extrapyramidal features, digital malformations and intellectual disability.
Features include: Facial palsy, Mask-like facies, Telecanthus, and Intellectual disability and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Intellectual disability, Torsion dystonia |
Head and neck |
Biomarker and diagnostic research for blepharonasofacial malformation syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for blepharonasofacial malformation syndrome.
166 publications have been identified in PubMed for blepharonasofacial malformation syndrome. Research spans Review / Meta-Analysis (49%), Basic Science / Preclinical (20%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 81 | 49% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1
Facial palsy |
Laboratory research
33 |
20% |
Disease patterns and progression | 16 | 10% |
Patient case studies | 12 | 7% |
Other research | 9 | 5% |
Testing and diagnosis research | 9 | 5% |
Clinical study results | 5 | 3% |
New treatment approaches | 1 | 1% |
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Epidemiology / Natural History]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Küçükşen MF (2026). [PMID: 41308821](https://pubmed.ncbi.nlm.nih.gov/41308821/). *The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons*. [Other]
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Current opinion in gastroenterology*. [Review / Meta-Analysis]
Mountford R (2026). [PMID: 41637667](https://pubmed.ncbi.nlm.nih.gov/41637667/). *Eur J Pain*. [Review / Meta-Analysis]
Manto M (2025). [PMID: 40973040](https://pubmed.ncbi.nlm.nih.gov/40973040/). *Arquivos de neuro-psiquiatria*. [Review / Meta-Analysis]
Lv M (2025). [PMID: 40160217](https://pubmed.ncbi.nlm.nih.gov/40160217/). *Vascular health and risk management*. [Clinical Trial Publication]